About this trial
Ongoing registration of patients with varicose veins disease treated by means of conventional surgery, endovenous thermal ablations, sclerotherapy, non-tumescent non-thermal methods
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Varicose veins with any source of pathological reflux, C2 - C6 according to the CEAP classification
Disqualifiers
no exclusion criteria
Trial population
Patients undergoing interventions in cases varicose vein disease
Trial design
Other
Prospective
Treatments tested in this trial
conventional surgery
Procedure/Surgeryhigh ligation and stripping of incompetent saphenous veins
endovenous laser ablation
Procedure/Surgeryendovenous laser ablation of incompetent saphenous veins
sclerotherapy
Procedure/Surgeryultrasound guided or catheter or or any other methods sclerotherapy of incompetent saphenous or varicose veins
endovenous radiofrequency ablation
Procedure/Surgeryendovenous radiofrequency ablation of incompetent saphenous veins
phlebectomy
Procedure/Surgeryhooks phlebectomy of varicose veins
Treatment groups
Trial outcomes
Primary outcomes
Change in patency target veins assessed by duplex ultrasonography in different follow up periods after conventional surgery, endovenous thermal ablations, sclerotherapy or non-tumescent non-thermal methods
Secondary outcomes
Change in Quality of Life (QoL), assessed by Short form (SF)-36 health survey (optional)
The SF-36 is a generic QoL questionnaire.
Change in Venous Clinical Severity Score (VCSS) (optional)
The VCSS is a validated scoring system for assessing signs, symptoms and complaints of venous disease.
Change in Quality of Life (QoL), assessed by Aberdeen Varicose Vein Questionnaire (AVVQ) (optional)
The AVVQ is a disease-specific QoL questionnaire aimed at venous disease.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Medalp Private Surgery Clinic
Lead sponsor
Pirogov Russian National Research Medical University
Collaborator